TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADRX
Line item 2024 2025
– +117.5%
– +118.6%
– +374.0%
– +91.6%
– +241.1%
– +334.2%
– –
– –
– +0.0%

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?